Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS2581038 A
Publication typeGrant
Publication dateJan 1, 1952
Filing dateApr 19, 1949
Priority dateOct 1, 1948
Publication numberUS 2581038 A, US 2581038A, US-A-2581038, US2581038 A, US2581038A
InventorsMiddendorf Leonhard
Original AssigneeHoechst Ag
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Choline preparations
US 2581038 A
Abstract  available in
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Patented Jan. 1, 1952 UNITED STATES PATENT OFFICE CHOLINE PREPARATIONS No Drawing. Application April 19, 1949, Serial No. 88,500. In Germany October 1, 1948 4 Claims. (Cl. 16782) The present invention relates to cholin preparations and to a process of preparing them.

Up to the present time it has appeared to be virtually impossible to administer by mouth the hygroscopic salts of choline and the compounds thereof, which salts have long been well known as parasympathetic stimulating drugs, that is they manifest a vasodilatory, blood pressure lowering and gastro-intestinal peristalsis promoting action. These bodies have an extremely unpleasant taste which cannot be masked by additions. After ingestion these bodies cause a very disagreeable eructation. The patient cannot be expected to tolerate the oral administration of the drug in a liquefied form. Furthermore, the specifled salts, as for instance the chlorides of choline and acetyl choline, may easily provoke irritation of the various mucous membranes. These disadvantages are still further aggravated by the fact that for instance acetyl-choline is quickly rendered inefiective in the body by the blood ferments, so that relatively large and frequent doses must be administered to ensure therapeutic success. Moreover the specified compounds are of a hygroscopicity such that it has hitherto not been feasible to process them in the required dose to reasonably stable, formed and orally applicable preparations, such as tablets, pills or capsules. For all these reasons these compounds have long been almost exclusively utilized for parenteral or rectal administration.

Now I have found that the hygroscopic salts of choline and its compounds can be prepared in a form for oral administration meeting all requirements of practice by processing these compounds, after liquefaction with water and/or another liquefying agent, with a physiologically tolerable fat, oil, higher hydrocarbon or the like to concentrated, finely dispersed, stable emulsions of the water-in-oil type. These emulsions are, for example, filled into gelatin, polyvinyl alcohol or the like capsules, which are sufiiciently soluble in the digestive juice.

Such capsules are swallowed whole, thus avoiding the disadvantage of the unpleasant taste of the drug. On account of the fact that the homogeneously dispersed active substance in the emulsion constitutes the disperse phase, being surrounded by the oily phase, contact with the mucous membranes of the gastro-intestinal tract, after the dissolving of the walls of the capsules in the digestive juice, is more uniform and only occurs gradually. In this way, as experience has shown, the disagreeable eructation as well as irritation of the mucous membranes of the gastrointestinal tract are suppressed without causing a reduction of the pharmacological properties of the drug. In order to cause the dissolving to occur entirely in the intestine, gelatin capsules may, if desired, be treated in the known manner with formaldehyde, by means of which they are rendered insoluble in the gastric juice.

The hygroscopicity of the choline compounds has been rendered ineffective by the dispersion in the fatty emulsion phase. The capsules manufactured according to the above-mentioned process may, therefore, be stored for years without undergoing any detrimental change.

The following example serves to illustrate the invention, but it is not intended to limit it thereto, the parts being by weight:

parts of choline chloride are converted into the liquid form by addition of 25 parts of distilled water and thereupon this liquid product is processed with a mixture con sisting of 25 parts of wool fat and 50 parts of fatty oil to a homogeneous emulsion which is viscous at room temperature.

This emulsion is filled into soft, easily swallowed gelatin capsules.

I claim:

1. A capsule soluble in digestive juice and containing an emulsion of liquefied hydrated choline chloride as the dispersed phase in a physiologically tolerable oleaginous medium of the class consisting of fats and higher hydrocarbons.

2. A water-in-oil wool-fat-containing emulsion of liquid hydrated choline chloride in a fatty oil.

3. An orally administrable pharmaceutical capsule made of material soluble in digestive juice and containing a water-in-oil emulsion of liquid hydrated choline chloride in a fatty oil.

4. The combination as defined by claim 3 in which the capsule material is insoluble in gastric juice.


REFERENCES CITED The following references are of record in the file of this patent:

FOREIGN PATENTS Number Country Date 593,271 Germany Feb. 23, 1934 OTHER REFERENCES Dimitry'Urologic 8 Cutaneous Review, vol. 49, Feb. 1945, pp. 91, 92 (Copy in Div. 43). l

U. S. Dispensatory, 24th Ed. (1947) pp. 1400, 1401 (Copy in Div. 43).

U. S. Dispensatory, 23d Ed. (1943) p. 258 (Copy in Div. 43).

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
DE593271C *Nov 7, 1931Feb 23, 1934Karl Luedecke DrMit waessrigen Emulsionen oder Loesungen gefuellte Gelatinekapsel
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US2772998 *Nov 7, 1952Dec 4, 1956Benckiser Gmbh Joh ACholine salt tablet and process of making same
US2917468 *Mar 21, 1956Dec 15, 1959Bayer AgSurface active polymeric trimethylene oxide derivatives with polyether sidechains, and process for producing same
US3126321 *Jan 26, 1962Mar 24, 1964 Table vii
US3627693 *Jan 28, 1970Dec 14, 1971Ncr CoLayered capsule walls and a method for manufacturing them
US5190775 *May 29, 1991Mar 2, 1993Balchem CorporationEncapsulated bioactive substances
US6013286 *Dec 8, 1992Jan 11, 2000Balchem CorporationEncapsulated bioactive substances
US6881482Aug 16, 2002Apr 19, 2005Southwest Research InstituteMicroencapsulation using electromagnetic energy and core and shell materials with different dielectric constants and dissipation factors
US7140874Aug 6, 2002Nov 28, 2006Southwest Research InstituteMethod and apparatus for testing catalytic converter durability
US7625201Sep 6, 2006Dec 1, 2009Southwest Research InstituteMethod and apparatus for testing catalytic converter durability
US20030062641 *Aug 16, 2002Apr 3, 2003Niraj VasishthaMicroencapsulation using electromagnetic energy and core and shell materials with different dielectric constants and dissipation factors
US20080070169 *Sep 6, 2006Mar 20, 2008Ingalls Melvin NMethod and apparatus for testing catalytic converter durability
U.S. Classification424/455, 514/642
International ClassificationA61K31/185, A61K31/195
Cooperative ClassificationA61K31/195
European ClassificationA61K31/195